Label-free Array Systems

Label-free Array Systems

Global Label-free Array Systems Market to Reach $1.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Label-free Array Systems estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Surface Plasmon Resonance (SPR), one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bio-layer Interferometry (BLI) segment is readjusted to a revised 4.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $375.2 Million, While China is Forecast to Grow at 5.1% CAGR

The Label-free Array Systems market in the U.S. is estimated at US$375.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$323.5 Million by the year 2027 trailing a CAGR of 5.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Cellular Dielectric Spectroscopy (CDS) Segment to Record 5.2% CAGR

In the global Cellular Dielectric Spectroscopy (CDS) segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$58.5 Million in the year 2020 will reach a projected size of US$84.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$204.3 Million by the year 2027.

Select Competitors (Total 43 Featured) -

  • Agilent Technologies, Inc.
  • Attana AB
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • ForteBio
  • GWC Technologies
  • Molecular Devices LLC
  • PerkinElmer, Inc.
  • Riot Blockchain, Inc.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Label-free Array Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Label-free Array Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Label-free Array Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for Surface Plasmon Resonance (SPR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Surface Plasmon Resonance (SPR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Surface Plasmon Resonance (SPR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for Bio-layer Interferometry (BLI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Bio-layer Interferometry (BLI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Bio-layer Interferometry (BLI) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for Quartz Crystal Microbalance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Quartz Crystal Microbalance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Quartz Crystal Microbalance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 19: World Current & Future Analysis for Antibody Characterization and Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Antibody Characterization and Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Antibody Characterization and Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 22: World Current & Future Analysis for Protein Interface Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Protein Interface Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Protein Interface Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 25: World Current & Future Analysis for Protein Complex and Cascade Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Protein Complex and Cascade Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Protein Complex and Cascade Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 28: World Current & Future Analysis for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for R&D Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 31: World Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: World 15-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 34: World Current & Future Analysis for Agriculture Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 35: World Historic Review for Agriculture Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: World 15-Year Perspective for Agriculture Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 37: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 40: USA Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: USA Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: USA 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
TABLE 43: USA Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: USA Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: USA 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
TABLE 46: USA Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: USA Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: USA 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
TABLE 49: Canada Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Canada Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Canada 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
TABLE 52: Canada Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Canada Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Canada 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
TABLE 55: Canada Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: Canada Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: Canada 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
TABLE 58: Japan Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: Japan Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: Japan 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
TABLE 61: Japan Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: Japan Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: Japan 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
TABLE 64: Japan Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Japan Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Japan 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
TABLE 67: China Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: China Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: China 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
TABLE 70: China Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: China Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: China 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
TABLE 73: China Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: China Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: China 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
TABLE 76: Europe Current & Future Analysis for Label-free Array Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 77: Europe Historic Review for Label-free Array Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: Europe 15-Year Perspective for Label-free Array Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 79: Europe Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: Europe Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: Europe 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
TABLE 82: Europe Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: Europe Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: Europe 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
TABLE 85: Europe Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Europe Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Europe 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
TABLE 88: France Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: France Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: France 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
TABLE 91: France Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: France Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: France 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
TABLE 94: France Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: France Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: France 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
TABLE 97: Germany Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Germany Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Germany 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
TABLE 100: Germany Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook